Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)

AR Bourgonje, AE Abdulle, W Timens… - The Journal of …, 2020 - Wiley Online Library
Abstract Angiotensin‐converting enzyme 2 (ACE2) has been established as the functional
host receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus …

Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome

S Villapol - Translational Research, 2020 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the
greatest worldwide pandemic since the 1918 flu. The consequences of the coronavirus …

COVID-19: unmasking emerging SARS-CoV-2 variants, vaccines and therapeutic strategies

R Raman, KJ Patel, K Ranjan - Biomolecules, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of
the coronavirus disease 2019 (COVID-19) pandemic, which has been a topic of major …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a systemic infection

A Synowiec, A Szczepański… - Clinical microbiology …, 2021 - Am Soc Microbiol
To date, seven identified coronaviruses (CoVs) have been found to infect humans; of these,
three highly pathogenic variants have emerged in the 21st century. The newest member of …

COVID-19 and immunomodulation in IBD

MF Neurath - Gut, 2020 - gut.bmj.com
The current coronavirus pandemic is an ongoing global health crisis due to COVID-19,
caused by severe acute respiratory syndrome coronavirus 2. Although COVID-19 leads to …

Are patients with inflammatory bowel disease at increased risk for Covid-19 infection?

G Monteleone, S Ardizzone - Journal of Crohn's and Colitis, 2020 - academic.oup.com
Crohn's disease [CD] and ulcerative colitis [UC], the main inflammatory bowel diseases [IBD]
in humans, are chronic, immune-inflammatory diseases, the pathogenesis of which suggests …

[HTML][HTML] Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver

HY Lei, YH Ding, K Nie, YM Dong, JH Xu… - Biomedicine & …, 2021 - Elsevier
COVID-19 is a pandemic caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2). Early reported symptoms include fever, cough, and respiratory symptoms …

Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: a systematic review and meta‐analysis

AK Singh, A Jena, P Kumar‐M… - United European …, 2021 - Wiley Online Library
Background The risk of severe acute respiratory syndrome‐related coronavirus 2 (SARS‐
CoV‐2) infection and clinical outcomes of coronavirus disease (COVID‐19) in inflammatory …

2019 novel coronavirus disease (COVID‐19) in patients with inflammatory bowel diseases

C Taxonera, I Sagastagoitia, C Alba… - Alimentary …, 2020 - Wiley Online Library
Background Data on patients with inflammatory bowel diseases (IBD) who have had 2019
novel coronavirus (SARS‐CoV‐2) disease (COVID‐19) are needed. Aims To report the …

Inflammatory bowel disease management during the COVID-19 outbreak: the ten do's and don'ts from the ECCO-COVID taskforce

F Magro, JF Rahier, C Abreu… - Journal of Crohn's …, 2020 - academic.oup.com
Our knowledge of COVID-19 is changing and evolving rapidly, with novel insights and
recommendations, almost on a daily basis. It behooves the medical community to provide …